NASDAQ:DRUG
Bright Minds Biosciences Inc.
- Stock
Last Close
1.45
23/07 17:48
Market Cap
6.12M
Beta: 1.25
PE Ratio
−1.30
PFCF: −1.69
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Mar '20 | Jun '20 | Sep '20 | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -31.41K - | -16.73K 46.76% | -29.62K 77.12% | -402.62K 1,259.09% | -753.42K 87.13% | -1.50M 98.68% | -3.53M 136.05% | -2.87M 18.86% | -4.86M 69.45% | -4.49M 7.63% | -2.66M 40.76% | -2.96M 11.38% | -2.34M 21.13% | -2.05M 12.20% | -1.46M 28.88% | -1.53M 4.78% | -1.68M 10.23% | -574.14K 65.91% | |
depreciation and amortization | 6.04K - | 18.11K 200.02% | 18.11K 0.01% | 18.11K 0% | 18.11K 0.01% | 18.11K 0.01% | 18.11K 0.01% | ||||||||||||
deferred income tax | -6.04K - | -130.47K - | 163.44K 225.27% | 42.30K 74.12% | |||||||||||||||
stock based compensation | 161.30K - | 236.41K 46.57% | 6.84K 97.11% | 260.80K 3,713.36% | 376.56K 44.39% | 260.93K 30.71% | 290.83K 11.46% | 293.38K 0.88% | 29.91K 89.80% | 484.14K 1,518.40% | 29.96K 93.81% | 237.53K 692.95% | 400.50K 68.61% | 218.95K 45.33% | |||||
change in working capital | -28.32K - | -21.10K 25.50% | 49.42K 334.24% | 30.68K 37.91% | -94.37K 407.53% | 140.67K 249.06% | 6.67K 95.26% | 253.12K 3,697.15% | -162.47K 164.19% | 544.20K 434.96% | -501.36K 192.13% | 845.93K 268.73% | -837.55K 199.01% | 484.58K 157.86% | -322.00K 166.45% | -255.36K 20.70% | 579.85K 327.07% | -479.99K 182.78% | |
accounts receivables | -91.34K - | 96.50K 205.65% | 25.91K 73.15% | -70.31K 371.35% | 66.69K 194.85% | -8.06K 112.08% | -508.21K 6,206.10% | ||||||||||||
inventory | |||||||||||||||||||
accounts payables | |||||||||||||||||||
other working capital | 937.27K - | -934.05K 199.66% | 458.67K 149.10% | -251.69K 154.87% | -322.05K 27.96% | 587.91K 282.55% | 28.22K 95.20% | ||||||||||||
other non cash items | 3.80K - | 293.25K 7,621.22% | -152.29K 151.93% | -191.38K 25.67% | 6.99K 103.65% | 4.28K 38.80% | -43.42K 1,115.20% | 7.05K 116.23% | 2.00M 28,307.29% | 4.58K 99.77% | 3.79K 17.26% | 2.97K 21.53% | 775.37K 25,997.81% | ||||||
net cash provided by operating activities | -59.73K - | -37.82K 36.68% | 19.80K 152.34% | -210.63K 1,164.06% | -611.37K 190.26% | -1.35M 120.10% | -2.97M 120.92% | -2.39M 19.62% | -4.95M 107.19% | -3.65M 26.37% | -2.86M 21.49% | -2.13M 25.63% | -2.66M 25.14% | 484.58K 118.19% | -1.65M 440.62% | -1.20M 27.45% | -822.09K 31.35% | -805.09K 2.07% | |
investments in property plant and equipment | |||||||||||||||||||
acquisitions net | |||||||||||||||||||
purchases of investments | |||||||||||||||||||
sales maturities of investments | |||||||||||||||||||
other investing activites | |||||||||||||||||||
net cash used for investing activites | -11.19M - | ||||||||||||||||||
debt repayment | -24.84K - | -21.49K 13.49% | -21.49K 0.01% | -21.49K 0.00% | -21.64K 0.73% | -21.96K 1.44% | |||||||||||||
common stock issued | 91.68K - | -10K 110.91% | 926.65K 9,366.50% | 1.88M 102.48% | 25.91M 1,280.78% | -39.25K 100.15% | 4.03M - | 1.22M 69.83% | 900K - | ||||||||||
common stock repurchased | |||||||||||||||||||
dividends paid | |||||||||||||||||||
other financing activites | -1.17M - | -506.30K 56.85% | -9.70K 98.08% | 118.25K 1,319.07% | 1.68K 98.58% | 12K 612.59% | 1.05M 8,685.08% | 1.06M 0.39% | |||||||||||
net cash used provided by financing activities | 91.68K - | -10K 110.91% | 926.65K 9,366.50% | 1.88M 102.48% | 24.73M 1,218.25% | -545.55K 102.21% | -9.70K 98.22% | 118.25K 1,319.07% | 1.68K 98.58% | 12K 612.59% | 5.06M 42,102.13% | 2.25M 55.49% | -21.49K 100.95% | -21.49K 0.00% | -21.64K 0.73% | 878.04K 4,156.56% | -21.96K 102.50% | ||
effect of forex changes on cash | 75.30K - | 152.29K 102.25% | 191.38K 25.67% | -6.99K 103.65% | 22.97K 428.70% | 51.46K 123.99% | -7.05K 113.70% | -5.33K 24.37% | 130.47K 2,547.38% | -163.44K 225.27% | -42.30K 74.12% | ||||||||
net change in cash | -59.73K - | 53.86K 190.16% | 9.79K 81.81% | 716.02K 7,210.05% | 1.26M 76.66% | 23.39M 1,748.71% | -3.44M 114.72% | -2.25M 34.74% | -4.64M 106.56% | -3.65M 21.34% | -2.83M 22.56% | 2.99M 205.66% | -416.41K 113.94% | -10.73M 2,477.32% | -1.54M 85.64% | -1.38M 10.31% | 13.66K 100.99% | -829.21K 6,169.91% | |
cash at beginning of period | 79.99K - | 20.26K 74.67% | 74.11K 265.86% | 83.91K 13.22% | 799.93K 853.32% | 2.06M 158.13% | 25.45M 1,132.52% | 22.01M 13.53% | 19.76M 10.21% | 15.12M 23.49% | 11.47M 24.15% | 8.64M 24.65% | 11.63M 34.57% | 11.21M 3.58% | 9.67M 13.73% | 8.13M 15.94% | 6.75M 17.00% | 6.68M 1.08% | |
cash at end of period | 20.26K - | 74.11K 265.86% | 83.91K 13.22% | 799.93K 853.32% | 2.06M 158.13% | 25.45M 1,132.52% | 22.01M 13.53% | 19.76M 10.21% | 15.12M 23.49% | 11.47M 24.15% | 8.64M 24.65% | 11.63M 34.57% | 11.21M 3.58% | 479.25K 95.73% | 8.13M 1,596.53% | 6.75M 17.00% | 6.76M 0.20% | 5.85M 13.54% | |
operating cash flow | -59.73K - | -37.82K 36.68% | 19.80K 152.34% | -210.63K 1,164.06% | -611.37K 190.26% | -1.35M 120.10% | -2.97M 120.92% | -2.39M 19.62% | -4.95M 107.19% | -3.65M 26.37% | -2.86M 21.49% | -2.13M 25.63% | -2.66M 25.14% | 484.58K 118.19% | -1.65M 440.62% | -1.20M 27.45% | -822.09K 31.35% | -805.09K 2.07% | |
capital expenditure | |||||||||||||||||||
free cash flow | -59.73K - | -37.82K 36.68% | 19.80K 152.34% | -210.63K 1,164.06% | -611.37K 190.26% | -1.35M 120.10% | -2.97M 120.92% | -2.39M 19.62% | -4.95M 107.19% | -3.65M 26.37% | -2.86M 21.49% | -2.13M 25.63% | -2.66M 25.14% | 484.58K 118.19% | -1.65M 440.62% | -1.20M 27.45% | -822.09K 31.35% | -805.09K 2.07% |
All numbers in USD (except ratios and percentages)